Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

A Systematic Review of Newer Drugs for Glucose Control Posted: Sunday, February 06, 2011

The National Institute for Health and Clinical Excellence (NICE) issued an updated Guideline for newer drugs for the management of all aspects of Type 2 diabetes. The guidelines review the newer agents from four classes with a cost analysis.

For Those 60 Percent of Type 2 Patients Who Are Not in Control Posted: Saturday, January 29, 2011

Consider a GLP-1 plus a long-acting insulin.

Why Don't People Take Their Insulin as Prescribed? Posted: Sunday, January 23, 2011

Risk factors differed between Type 1 and Type 2 diabetic patients, with diet nonadherence more prominent in Type 1 diabetes.

Race/Ethnicity Plays A Role in the Efficacy of Insulin Regimens Posted: Sunday, January 23, 2011

Latino/Hispanic, Asian, and African-descent patients with Type 2 diabetes show different metabolic responses to insulin therapy, dependent in part on insulin type and regimen intensity.

FDA Still Inconclusive about Lantus Cancer Risk Posted: Sunday, January 23, 2011

Eighteen months after starting a probe of potential cancer risks associated with insulin glargine (Lantus), the FDA still hasn't decided whether the concern is justified.

Birch Bark Ingredient Has Metabolic Benefits Posted: Wednesday, January 19, 2011

In mice, a compound known as betulin lowered cholesterol, helped prevent diet-induced obesity and improved insulin sensitivity.

Team-Based Approach Benefits Patients with Depression and Diabetes, Heart Disease Posted: Wednesday, January 19, 2011

Many people have multiple common chronic diseases such as diabetes and cardiovascular disease, complicating healthcare needs.

The Tummy Tube That May Save Millions Posted: Monday, January 10, 2011

A new treatment for obesity and diabetes could save enough money to have a sizeable impact on the economy, a surgeon claims.

Researchers Uncover Mechanism for Chronic Inflammation in Type 2 Diabetes Posted: Monday, January 10, 2011

Researchers from Boston University School of Medicine have demonstrated that certain T cells require input from monocytes in order to maintain their pro-inflammatory response in people with Type 2 diabetes.

What Are Your Waiting for? Start Metformin Early Posted: Tuesday, January 04, 2011

For newly diagnosed Type 2 diabetes patients, waiting until lifestyle measures fail before starting metformin may jeopardize the long-term efficacy of the drug.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.